FDA inspection
Biotest Pharmaceuticals Corporation: FDA inspection ending Nov 30, 1999
FDA inspection 4973 · No Action Indicated (NAI) · Gainesville, FL
Key facts
| Inspection ID | 4973 |
|---|---|
| Firm | Biotest Pharmaceuticals Corporation |
| FEI number | 1072432 |
| Address | 2315 Nw 13th St |
| City | Gainesville |
| State | FL |
| ZIP | 32609-2839 |
| Fiscal year | 2000 |
| Inspection end date | Nov 30, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood & Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data